eCONSENT

EvidentIQ eConsent improves trial participants experience by meeting them where they are.
It enables the improved quality and efficiency of clinical trials through insight into the patient experience, improved data quality and a fully electronic experience. 

patient ipad
FASTER RECRUITMENT AND REDUCTION OF STUDY DURATION

eCONSENT

Today, study sponsors must find new ways to ensure that potential patients are fully informed, despite the multitude of information provided, traditionally on paper.

Electronic informed consent (eConsent) provides the same information, but in an electronic format that may include multimedia components such as images, audio, video, diagrams, reports and a digital signature which may aid the comprehension and consenting process with less effort.

THE PROBLEM WITH PAPER DRIVEN INFORMED CONSENT
0 %
Of eligible patients do not enroll due to a lack of understanding regarding study specifics.
0 %
Of eligible patients dropout due to misunderstood expectations.
Paper informed consents do not promote consistent dialogue and informed decision making.

FEATURES

EASE WORKLOAD FOR STUDY TEAMS AND SITES

Simplify and speed up the consent process

Recruit your participants through a customized recruitment portal and pre-screen with questionnaires to help filter appropriate participants. Allows collection of your subject eligibility status (pending, pass, and fail) including the timestamp of when this was updated. After consent, patient data from enrolled participants can automatically be updated in Marvin EDC, ready for the next step. 

ENHANCING PATIENT UNDERSTANDING

Helping to provide the patient with the full picture

With information provided on a handwritten form the patient may not get the fullest possible account of the risks and benefits associated with the procedure they are considering. Important points may be abbreviated, illegible or missed altogether.

EvidentIQ econsent offers a wide range of eConsent design capabilities including  embedded  video, graphics, PowerPoint, PDF files for patients to review, consent acknowledgement checks.

Furthermore, the patient will receive the most recent versions of any associated information leaflets for the procedure and can be provided with a link to an electronic copy of the form in addition to (or in place of) a printed copy.

REGULATORY COMPLIANT VIDEO CALLING

Minimize costs, risks, and administrative burdens of in-person site visits

Patients can self-schedule assessments or request remote “walk-in” consultations. Engage participants in the comfort of their home. No switching between applications – video calls, signatures, and questionnaires are all built-in to reduce complexity and increase your patient’s experience.

BENEFITS

eConsultation

Depending on the trial it is possible as patient to get in touch with study personnel to ask further questions. No third party plugin or download required. Ensure transparency and enhance study comprehension for study subjects with secure, encrypted video calling.

eSignature

21 CFR Part 11 and Annex 11 electronic signature compliant and industry leading encryption, protects patient privacy, and ensures tamper-proof eConsent. Full audit trail and multi-factor authentication ensure ease of use and security.

Full Control

Patient details can be seen during the consultation. Patient questions can be picked-up and study personnel can share all the media interactively.

eEnrolment

Leverage Patient Poll . EvidentIQs Patient Community to automate EDC enrolment. (500,000 members based in Europe and the U.S.)

Provide a Multimedia Experience

Ease participants through steps. Wide range of eConsent design capabilities including embedded video, graphics, PowerPoint, PDF files for patients to review, consent acknowledgement checks.

Allow Participant Device of Choice

Boost participants engagement. EvidentIQ eConsent is a user-friendly application that can be accessed on any device using a modern browser such as Edge, Chrome, Firefox and Safari.
RESOURCES

EvidentIQ and Feel Therapeutics Launch Strategic Partnership

April 5th, 2022, Hamburg (GERMANY). Today, EvidentIQ, a leading clinical data science group, announced its partnership with Feel Therapeutics, a US-based digital biomarkers and therapeutics ...

Learn More

Amplifying Data Science Tools for End-to-End eClinical Solutions

On December 7th, Andreas Weber, Group CEO at EvidentIQ, sat down with Natalie Yeadon, Co-Founder & CEO at Impetus ...

Learn More

eConsent – Improve trial participants experience by meeting them where they are

Looking for a way to digitize the Informed Consent process and facilitate your clinical trials? On November ...

Learn More

EvidentIQ and Feel Therapeutics Launch Strategic Partnership

April 5th, 2022, Hamburg (GERMANY). Today, EvidentIQ, a leading clinical data science group, announced its ...

Learn More

Get a Demo

Let us show you how we can help you and your business

Schedule a Meeting

Let’s start a new project together

Request for Proposal

Discover a solution tailored to your needs
TRUSTED BY THE WORLD'S LEADING COMPANIES